Alternative Investing Forum - October 18, 2021
Master of Ceremonies
Master of Ceremonies
Adryenn Ashley, Founder & CEO, Wow is Me
Adryenn Ashley is a sought after speaker in the blockchain investor space. As a mentor to startups worldwide, she uses her well-honed techniques to transform worthy projects into investible assets that build community.
In addition, her work teaching family offices and hedge funds the art of due diligence in blockchain projects has made her the go-to expert with investors with enviable deal flow.
About Wow! Is Me
Your single destination for all things Blockchain and NFTs. We’ll help you build thriving and engaged communities providing direct access to your fans.
Delilah Panio, Vice President, US Capital Formation, TMX Group
Delilah Panio is Vice President of U.S. Capital Formation for Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) based in Southern California. In this role, Delilah advises U.S. companies on the opportunity to list and raise capital on Canada’s premier equity markets.
Delilah is also the founder of Fortuna Funding and works with women entrepreneurs to get investor-ready. She is a frequent speaker and pitch competition judge and coach, and was named in the “2019 Top 100 People in Finance” Magazine.
Previously, Delilah spent 10 years at TSX and TSXV in business development and strategy. She has advised many companies on the going public process and provides an understanding of private and public financing options in Canada and the U.S.
Delilah is an Advisory Board Member for MAPLE Business Council, a trade organization between Canada and Southern California, and is Co-Chair of the Capital Council for WE Global, an innovation studio for women entrepreneurs.
Delilah is also the Executive Director and Co-Founder of We Are Enough, a non-profit that educates women on why and how to invest in women-owned businesses and/or with a gender lens.
Delilah holds an MBA in Enterprise Development and a BA in English and has completed a certification as a Neuro-Linguistic Programming (NLP) Master Practitioner.
About Toronto Stock Exchange
Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) are a unique funding and listing platform for high growth US companies looking to raise Series B+ capital. Companies with early revenue, a strong management team, and a growth strategy to eventually list on a US exchange should consider the Canadian capital markets as an alternative that may be the right fit.
John Nemanic, Partner, Green Coast Capital
John Nemanic is a partner in Green Coast Capital International S.A. Green Coast is an international investor providing flexible and innovative financing to the small-cap and micro-cap marketplace in a variety of sectors. Our team consists of experts in capital markets making quick decisions to provide growth capital to issuers.
John is a serial entrepreneur and investor. As co-founder, Chairman and CEO, he exited 3 very successful Internet start ups. In 2006, Hostopia raised 29.2 million (TSX:H), then sold to Deluxe Communications for $124 Million USD. Tucows was sold to the Steinmetz Group for $45 Million April 1999. Tucows current market cap. is over $600 Million. Internet Direct was merged with Look Communications in 1999 with a deemed value of $560 Million
John's current interests are medical cannabis, cultivation, hemp and CBD start ups, with a focus on Colombia. He is married to Sandra Carrillo MD a leading expert in Cannabis for clinical applications, and was appointed as "Clinical professor in charge of the scientific program for cannabis research and education", Faculty of Medicine, University of Panama.
John manages Panamanian and Colombian based businesses. He is a former member of EO Panama and has extensive contacts within Panama. He also is a former member of EO Toronto (1995) and YPO Toronto (1999).
He is actively seeking high-return opportunities to invest in and serve as a director for high-quality cannabis oriented firms. If you are seeking a highly experienced operator, a dynamic leader who understands the growth cycles of start-ups, and how to develop exit strategies please contact John Nemanic.
About Green Growth Partners
Green Coast Capital International S.A is a private international investment firm focused on investing in small- and micro-cap publicly traded growth companies. We provide flexible debt and equity structured investments across several international markets.
We seek to invest in high growth and distressed situations. Green Coast Capital International S.A allocates capital across all industries in four core strategies: discounted equity, convertible debt, convertible preferred equity, and undervalued open market opportunities.
We only manage our own capital giving us the ability to make timely and qualified investment decisions.
Jonathan Pappie, CEO, VX Global
Jonathan is a corporate financial consultant who has relationships with traditional financial institutions, equity sources and alternative finance.
His commentary has been published by the World Bank, he was appointed to the Reagan Congressional Commission by the Republican National Trust, and he has worked with the Small Business Administration Advocates Office and the SEC’s Small Business Issuers Advisory Committee.
VX Global is a capital stack accelerator and a Platform based Investment and Debt marketing firm. We work with signed Associates who have Fortune 500 experience and Big 4 backgrounds, who are also interested in working with smaller companies. We help client company's, Boutique Investment Firms, Family offices and CFO's achieve realistic goals through an analysis of available resources with targeted efforts and automated investment systems.
Kevin Brooks , CEO, Conception Nurseries
Prior to his current role at Conception Nurseries, Kevin built and served as CEO of one of the largest vertically-integrated cannabis companies in California. The company was known for successfully developing some of the most well known super premium cannabis products on the market which has influenced pop culture worldwide. Before entering the cannabis industry, Kevin spent 13 years as a Senior Executive in Silicon Valley in the highly regulated legal technology space and has led companies through multiple successful exits.
About Conception Nurseries
Conception Nurseries brings commercial scale tissue culture technology to the cannabis industry through TrueClone technology. Harnessing state-of-the-art AgTech equipment and techniques, Conception Nurseries produces pathogen-free clones of exceptional vigor below commercial cultivator's in-house nursery costs. In 2020, Conception won the prestigious Ready to Invest™ award from The Arcview Group, was named a Top Ten Cannabis Tech Solution Provider by Enterprise Technology Review and selected as One of the Top 30 Fastest-Growing Private Companies to Watch in 2021 by the Silicon Review
Patrick Gorrell, Founder, Trees and Clouds
Patrick Gorrel is a serial entrepreneur and founder of Trees N Clouds, Inc.
Patrick also was the founder of FRST who were invited to be a speaker at the 2018 World Economic Forum in Davos. FRST raised $3.5MM for High Frequency Trading software for cryptocurrencies & digital assets. FRST (Financial Resources Statistics and Technologies) was the leader in on chain personification of wallet activity.
Prior to FRST Patrick was the VP Technlology Development and CTO for Speakr Inc. recognized by the 2016 Deloitte Fast 500 as one of the fastest growing tech companies in North America. Managing over 250,000 of the worlds most influential social profiles and aggregating over 300 Million profiles daily, Speakr was considered the world largest social data mining and analytics platform and earliest pioneers in predictive influencer behavior, performance, and analytics.
About Trees and Clouds
Trees and Clouds creates decentralized markets that allow traditional equity holders in the Cannabis Industry to access digital assets.
For instance, you can take Cannabis stocks and park them in an account and leverage against those assets with digital currencies.
Cannabis stocks are notoriously illiquid due to regulatory issues. Our products will create liquidity for investors in cannabis stocks to unlock trapped assets.
Peter Kasper, CEO & Founder, Terpli
Peter Kasper is the Founder & CEO of Terpli, a community-powered mobile app for cannabis recommendations and reviews. Peter launched Terpli while enrolled full-time in the MBA Program at USC, Marshall. He has dedicated his life and career to the cannabis industry and recently had the privilege of founding and leading the Marshall Cannabis Industry Club, USC Marshall's first-ever business of cannabis organization. With a finance and applied mathematics background, Peter eagerly brings his quantitative nature to the cannabis space and is excited to launch Terpli in the summer of 2021.
Terpli is a community-powered app where users can engage with reviews, get discounts, and see full Cannabinoid and Terpene profiles to make informed, personalized cannabis decisions. There’s so much more to cannabis than indica or sativa. Terpli is elevating the conversation. From peer-driven reviews and targeted recommendations to an analytics dashboard that enables brands to act on consumer preferences, Terpli is the go-to destination for making data-backed cannabis decisions before the point of purchase.
Dr. Sandra Carrillo, Co-Founder, Medicann IPS
Dr. Sandra Carrillo earned her Medical Doctor degree from Universidad CES in Medellin, Colombia. She holds a Master’s degree in Aesthetic Medicine from Baleares Island University in Spain and completed a Masters program of Anti-aging and Aesthetic Medicine in Argentina certified by the International Antiaging Society.
Dr. Carrillo further holds a Masters in Health Services Management, Universidad Latina in Panama, and is certified by Pharmacology University, a Medical Cannabis Institute, as an E xpert Doctor in Cannabis Medicine, Puerto Rico. She completed the University of Toronto Faculty of Medicine CCIC.net Cannabis training program for MD’s, Cannaciencia Seminars Bogota, , Curso Actualizacion sobre las Aplicaciones Terapeuticas de los Canabinoides Universidad CES Medicine, Medellin, and Cannaworld Medical Congress, Medellin. Dr. Carrillo is a member of the International Association for Cannabinoid Medicines and completed a Certificate Program in Cannabis Medicine from Oaksterdam University, California. She is an advocate for the Legalization of Cannabinoids for Medical purposes. Sandra is fluent in Spanish and English, and conversational in French.
Sandra is a co-founder of the Panama food bank and a volunteer at the Children's Epilepsy Foundation in Panama.
About Medicann IPS
Dr. Thomas Swanson, Co-Founder & CEO, Sativa Science
Tom is a Mayo Clinic and University of Pennsylvania trained epileptologist and neuroscientist who has been practicing neurology for over 30 years. He has been the lead investigator on several clinical drug trials and his laboratory has explored cellular and synaptic mechanisms of drug actions on human and animal brains. Dr. Swanson brings over 10 years of clinical experience with patients using cannabinoids. His understanding of mechanisms of cannabinoid action at both the clinical and scientific levels has been instrumental in driving our product development.
About Sativa Science
Bringing data-driven science to cannabis use!
At Sativa Science, our mission is to provide ethically sourced, science-driven data to enhance the safety and well-being of marijuana users. We strive to provide all clients with beneficial practices, positive outcomes, and knowledge to sustain an effective treatment.
When neurologist Dr. Thomas Swanson opened his Montana Comprehensive Epilepsy Program in Missoula 13 years ago, he was surprised by the swelling numbers of patients asking him about medical marijuana to alleviate symptoms associated with epilepsy and several other mental disorders. Despite decades of treatment experience, Dr. Swanson could find little to no information regarding medical marijuana. This alarmed him, especially in Montana where medical marijuana has been legalized since 2004.
“I was immediately concerned about the scarcity of scientific guidance as to the use of these products. There was no mechanism to guide dosing or strain-choice, and cannabis took up more and more of my visit time with patients.”
Dr. Swanson knew a solution was needed.
His first instinct was to confide in colleagues across the country. As a seasoned clinician with experience in patient care, pharmaceutical trials, disease exploration and investigative grants, Dr. Swanson had a surplus of researchers and physicians to connect with. However, his concerns were validated as his colleagues reported that their patients could access and select medical marijuana without any form of scientific evidence. The height of Dr. Swanson’s concern was rooted in the absence of tracking adverse effects, the scarcity in monitoring efficacy in regards to strain and dosage, limited scientific studies on specific cannabinoid effects, and the lack of knowledge about drug-drug interactions behind the marijuana prescriptions.
Dr. Swanson promptly enlisted his son, Mark Swanson, to develop the solution. Mark, a computer programmer, web designer, and coder, devised a science-based, cloud tracking system to catalogue and analyze client use of medical marijuana. Mark has drawn from his extensive experience designing tools and programs for medical research, programs used by the University of Michigan Center for Bioethics and Social Sciences in Medicine and the Wisconsin based website Earthling Interactive. This background has given Mark the expertise to create our program, Lumina.